The path from promising scientific insight to an Investigational New Drug (IND) application is both exhilarating and unforgiving. Regardless of how breakthrough the science may be, success depends on ...
The BBC's State Department correspondent and Washington correspondent explain how the president is justifying the action and assess the risks ahead.